Skip to content
Preprint · CC-BY via OpenAlex

DNA- and telomere-damage does not limit lifespan: evidence from rapamycin

Mikhail V. Blagosklonny

Aging · 2021 · ▲ 11 citations

Abstract

Failure of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) to extend lifespan in DNA repair mutant and telomerase-knockout mice, while extending lifespan in normal mice, indicates that neither DNA damage nor telomere(definition) shortening limits normal lifespan or causes normal aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/aging.202674
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Blagosklonny, M.V. (2021). DNA- and telomere-damage does not limit lifespan: evidence from rapamycin. <em>Aging</em>. https://doi.org/10.18632/aging.202674
Vancouver
Blagosklonny MV. DNA- and telomere-damage does not limit lifespan: evidence from rapamycin. Aging. 2021. doi:10.18632/aging.202674.
BibTeX
@unpublished{mikhail2021DNAand, title = {DNA- and telomere-damage does not limit lifespan: evidence from rapamycin}, author = {Mikhail V. Blagosklonny}, journal = {Aging}, year = {2021}, doi = {10.18632/aging.202674}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

Wiener Medizinische Wochenschrift 2018
Citation only

Sarcopenia

▲ 102